Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.010
-0.135 (-3.26%)
Sep 10, 2026, 1:14 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 7.48 billion as of September 9, 2026. Its market cap has decreased by -48.57% in one year.
Market Cap
7.48B
Enterprise Value
7.90B
Revenue
1.14B
Ranking
n/a
PE Ratio
26.19
Stock Price
4.01
ChartMarket Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 7.48B, a decrease of -36.84%. That is a compound annual growth rate of -9.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 7.48B | -16.60% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 10.66B |
| GenFleet Therapeutics (Shanghai) | 10.19B |
| CStone Pharmaceuticals | 9.87B |
| LongBio Pharma (Suzhou) | 9.50B |
| Shaanxi Micot Pharmaceutical Technology | 9.47B |
| TenNor Therapeutics (Suzhou) | 8.79B |
| Alphamab Oncology | 8.49B |
| CARsgen Therapeutics Holdings | 7.55B |